CU6 clarity pharmaceuticals ltd
Add to My Watchlist 3.24% ! $2.23

Ann: First patient imaged in Phase III AMPLIFY trial, page-10

  1. Jdmoney
    2,281 Posts.
    lightbulb Created with Sketch. 424
    clock Created with Sketch.
    29/05/25
    12:12
    Post #: 79234565
    This is plumb normal for all biotechs that dose first patient. It is classified as PS.

    its like quarterlies for pre revenue companies. They're mostly all known info but marked as PS.
    CU6 Price at posting: $2.23 Sentiment: None Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Agreement for Sale of Mount Mason Project to Gold Valley Yilgarn
right-arrow Created with Sketch.
NEWS Pathological Complete Response Recorded in ACCENT Trial of Advanced Pancreatic Cancer
right-arrow Created with Sketch.
VMM Viridis Selected for BNDES and FINEP Strategic Mineral Funding to Advance Colossus Project
right-arrow Created with Sketch.
NEWS Bonanza Dittmer Drilling Hits 221g/t Gold in Stage 5 Intersection
right-arrow Created with Sketch.
NEWS High-Grade Gold Hits Extend Major Lodes at Kpali Prospect in Ghana
right-arrow Created with Sketch.
NEWS Building Permits Received for Phase One Renewable Power Plant
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$2.23 		Change
0.070(3.24%) 		Mkt cap ! $716.6M
Open High Low Value Volume
$2.15 $2.29 $2.13 $4.198M 1.899M

Buyers (Bids)

No. Vol. Price($)
1 4477 $2.22
 

Sellers (Offers)

Price($) Vol. No.
$2.23 9998 1
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.